Newsletter - October 4, 2011 - Latest Advances in Clinical Senology and Oncology


Published on

Published in: Health & Medicine
1 Like
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide Newsletter - October 4, 2011 - Latest Advances in Clinical Senology and Oncology

  1. 1. Senology Newsletter Page 1 of 3 - Newsletter International Senologic and Oncologic  Scientific Community  "Connecting specialists worldwide" Editor-in-Chief: Gian Paolo Andreoletti, MD Subscribe Unsubscribe Contact Back Issues Connecting Specialists Worldwide Join us on Facebook®, Twitter®, YouTube®, LinkedIn®, SlideShare®, Flickr® and Doctorsbook® and share informations, opinions and suggestions. Check out Newspaperand follow our RSS feeds for real-time updates Literature Selection Luo T et al.: "Aspirin use and breast cancer risk: a meta-analysis", Breast Cancer Res Treat. 2011 Sep 4. [Epub ahead of print] Hu F et al.: "Carotenoids and breast cancer risk: a meta-analysis and meta-regression", Breast Cancer Res Treat. 2011 Sep 7. [Epub ahead of print] Suhrke P et al.: "Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data", BMJ. 2011 Sep 13;343:d4692. doi: 10.1136/bmj.d4692 Ascunce N et al.: "Impact of intermediate mammography assessment on the likelihood of false- positive results in breast cancer screening programmes", Eur Radiol. 2011 Sep 8. [Epub ahead of print] Friedlander LC et al.: "Results of MR Imaging Screening for Breast Cancer in High-Risk Patients with Lobular Carcinoma in Situ", Radiology. 2011 Sep 7. [Epub ahead of print] Sung JS et al.: "Screening Breast MR Imaging in Women with a History of Lobular Carcinoma in Situ", Radiology. 2011 Sep 7. [Epub ahead of print] Arun B et al.: "Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience", J Clin Oncol. 2011 Sep 6. [Epub ahead of print] Bedognetti D et al.: "Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial", J Natl Cancer Inst. 2011 Sep 15. [Epub ahead of print] Le Scxodan R et al.: "Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death", BMC Cancer. 2011 Sep 19;11(1):395. [Epub ahead of print] 04/10/2011
  2. 2. Senology Newsletter Page 2 of 3 Griggs JJ et al.: "American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women With Early-Stage Invasive Breast Cancer", J Clin Oncol. 2011 Sep 6. [Epub ahead of print] Klimberg VS et al.: "Feasibility of Percutaneous Excision Followed by Ablation for Local Control in Breast Cancer", Ann Surg Oncol. 2011 Sep 9. [Epub ahead of print] Kauer-Dorner D et al.: "Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: Alternative to mastectomy", Radiother Oncol. 2011 Sep 8. [Epub ahead of print] Kiluk JV et al.: "Male Breast Cancer: Management and Follow-up Recommendations", Breast J. 2011 Sep;17(5):503-9. doi: 10.1111/j.1524-4741.2011.01148.x Discussion "Synchronous adjuvant chemoradiation in women with early breast cancer" - Share your opinion on LinkedIn®. Comment "Ipsilateral breast radiotherapy in patients with occult primary breast cancer presenting with axillary metastases" - Marina Parton, Breast Unit, The Royal Marsden Hospital and Institute of Cancer Research, London, UK ""Patients with axillary lymph nodes metastases from an occult primary breast cancer are recommended treatment to the ipsilateral breast following axillary surgery to reduce the risk of local relapse. Our study provides further evidence that radiation to the ipsilateral breast is a safe alternative to mastectomy, to which it is favourable given the cosmetic advantages of conserving the breast. No significant improvement in local control was seen using higher doses of radiotherapy than standard dose. Because of the risk of additional toxicity with increasing dose, standard dose radiotherapy is recommended" (Comment on: Barton SR et al.: "The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathy", Eur J Cancer. 2011 Jun 7. [Epub ahead of print]) Fragments of History William S Halsted (New York, 1852-1922), "The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894", Ann Surg. 1894 November; 20(5): 497–555: “The pectoralis major muscle, entire or all except its clavicular portion, should be excised in every case of cancer of the breast ." Calendar of Events 7th Meet the Professor. Modena International Breast Cancer Conference (MIBCC) October 5-7, 2011, Modena, Italy - under the Patronage of 8th Scientific Meeting of the Australasian Society for Breast Disease 6-8 October 2011, Melbourne, Australia 1st Advanced Breast Cancer International Consensus Conference, November 3-5, 2011, Lisbon, Portugal 33rd Congress of the French Senologic Society November 9-11, 2011 Marseille France AORTIC (African Organisation for Research and Training in Cancer) - 8th International Conference, November 28 - December 2, 2011, Cairo, Egypt Literature Selection Mariette X et al.: "Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis", Ann Rheum Dis. 2011 Sep 1. [Epub ahead of print] Burakgazi AZ et al.: "Longitudinal assessment of oxaliplatin-induced neuropathy", Neurology. 2011 Sep 6;77(10):980-6 Newton MJ et al.: "Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study", BMC Cancer. 2011 Sep 8;11(1):389. [Epub ahead of print] van Dam JM et al.: "Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate 04/10/2011
  3. 3. Senology Newsletter Page 3 of 3 receptor-α targeting: first in-human results", Nat Med. 2011 Sep 18. doi: 10.1038/nm.2472. [Epub ahead of print] Nicklin J et al.: "The utility of serum CA-125 in predicting extra-uterine disease in apparent early stage endometrial cancer", Int J Cancer. 2011 Sep 14. doi: 10.1002/ijc.26433. [Epub ahead of print] Cho E et al.: "Prospective evaluation of analgesic use and risk of renal cell cancer", Arch Intern Med. 2011 Sep 12;171(16):1487-93 Zamagni E et al.: "Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma", Ann Hematol. 2011 Sep 8. [Epub ahead of print] Zhang S et al.: "The combined treatment of CT-guided percutaneous (125)I seed implantation and chemotherapy for non-small-cell lung cancer", J Cancer Res Clin Oncol. 2011 Sep 16. [Epub ahead of print] Yeh CH et al.: "Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer", Int J Clin Oncol. 2011 Sep 22. [Epub ahead of print] Literature Selection Kreimer AR et al.: "Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine", J Natl Cancer Inst. 2011 Sep 9. [Epub ahead of print] Boekhout AH et al.: "Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial", J Clin Oncol. 2011 Sep 12. [Epub ahead of print] Castellsagué X et al.: "Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies", Lancet Oncol. 2011 Sep 12. [Epub ahead of print] collaborates with - "Breast cancer questions, answers, and support". Follow the Expert Q&A Workshops and join the conversation Unsubscribe       www.senology.org 04/10/2011